Nuclear Medicine: Page 28

PET/MRI shows prowess for nodal staging in breast cancer

By Amerigo Allegretto

Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-4 | Room TBAIn this presentation, researchers will compare nodal staging between CT, MRI, and FDG-PET/MRI in patients with newly diagnosed breast cancer.

November 15, 2021

Combining radiomics, AI with PET/MRI helps assess nodal status

By Amerigo Allegretto

Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-3 | Room TBAHere, researchers will talk about how applying radiomics and machine learning to FDG-PET/MRI can noninvasively assess nodal status and treatment planning for breast cancer patients.

November 15, 2021

Combining radiomics, AI with PET/MRI helps assess nodal status

By Amerigo Allegretto

Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01‐3 | Room TBAHere, researchers will talk about how applying radiomics and machine learning to FDG-PET/MRI can noninvasively assess nodal status and treatment planning for breast cancer patients.

November 14, 2021

ANSTO to partner with Cyclotek on theranostics facility

By AuntMinnie.com staff writers

The Australian Nuclear Science and Technology Organisation (ANSTO) is entering into a joint venture with Cyclotek to build a new theranostics facility in Melbourne.

November 11, 2021

Clarity hits milestone in study of radiopharmaceutical

By AuntMinnie.com staff writers

Clarity Pharmaceuticals, the Australian-based radiopharmaceutical developer, has completed patient recruitment in the dosimetry phase of a study of its theranostic agent with copper-based radioisotopes for treating metastatic castration-resistant prostate cancer.

November 11, 2021

How can the clinical potential of PET/MRI be unlocked?

By Frances Rylands-Monk

Why are some countries lagging behind others when it comes to unlocking the clinical potential of PET/MRI? Cancer imaging expert Dr. Vicky Goh of the U.K. took out her crystal ball and provided some insight into the future role of PET/MRI and how both modalities can be integrated effectively.

November 10, 2021

Q BioMed partners with Eversana on Strontium89

By AuntMinnie.com staff writers

Biotech company Q BioMed has partnered with life sciences firm Eversana to support the commercialization of its Strontium89 therapeutic radiopharmaceutical in the U.S.

November 7, 2021

Best Theratronics lands multiple cyclotron orders

By AuntMinnie.com staff writers

TeamBest Global company Best Theratronics has garnered $30 million worth of international orders for new cyclotron systems and upgrades.

October 25, 2021

ITM secures supply deal with Clovis Oncology

By AuntMinnie.com staff writers

German radiopharmaceutical firm ITM Isotope Technologies Munich has signed an agreement to supply its EndolucinBeta no-carrier-added lutetium-177 radiopharmaceutical precursor to Clovis Oncology.

October 18, 2021

SPECT scans identify high-risk heart failure patients

By Will Morton

SPECT scans of patients hospitalized for heart failure can help predict their risk of further life-threatening events after they are discharged, according to a study published October 13 in JACC: Cardiovascular Imaging.

October 17, 2021

ARTMS seeks nod from Health Canada for Ga-68 production

By AuntMinnie.com staff writers

ARTMS has submitted a drug master file to the Health Products and Food Branch of Health Canada for the production of gallium-68 (Ga-68).

October 13, 2021

NorthStar breaks ground on isotope production facility

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has broken ground on the construction of a new therapeutic radioisotope production facility in Beloit, WI. The company has also installed new equipment for its accelerator production and isotope processing facilities.

October 13, 2021

Previous Page

Page 28 of 438

Next Page